Literature DB >> 9529057

Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.

Y Wang1, S P Li, S A Moser, K L Bost, J E Domer.   

Abstract

Candida albicans mannoprotein (MAN) administered intravenously to mice stimulates the production of splenic CD8+ effector cells which downregulate delayed hypersensitivity (DH) in immunized mice. Cytokine involvement in the induction and/or elicitation of downregulation was studied by (i) examining murine splenocytes qualitatively for mRNA for interleukin-2 (IL-2), IL-4, IL-10, IL-12p40, and gamma interferon (IFN-gamma), (ii) quantitating splenocyte mRNA for IL-12p40 by quantitative-competitive reverse transcriptase-mediated PCR, and (iii) measuring serum levels of IL-12p40 and IL-12p70 by capture enzyme-linked immunosorbent assay, each performed at selected intervals over 96 h after giving MAN. Further, the effect of in vivo administration of anti-IL-4 on the induction and elicitation of MAN-specific DH in MAN-treated mice was measured. Expression of IL-12p40 mRNA in the spleen was reduced to near 0 during the first 24 h but rebounded thereafter. Transcripts for IL-10 were present throughout the 96-h period, whereas those for IL-4 and IFN-gamma were either weak or undetectable prior to 24 to 48 h. In vivo administration of anti-IL-4 partially abrogated the downregulatory effect of MAN only when given at the time of MAN administration. Serum levels of IL-12p40, but not IL-12p70, were increased by 24 h and maximal at 48 h. The antagonistic effect of IL-12p40 could contribute to the mechanism(s) for downregulation of DH. Moreover, IL-10, IL-4, and/or IFN-gamma, interacting with MAN-activated cells in the absence of biologically active IL-12, may induce the production of CD8+ downregulatory effector cells. Partial abrogation of downregulatory activity in animals treated with anti-IL-4 at the time of induction of such activity lends support to this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529057      PMCID: PMC108064     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  70 in total

1.  Substance P-induced IL-12 production by murine macrophages.

Authors:  T Kincy-Cain; K L Bost
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

2.  Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice.

Authors:  E Balish; H Filutowicz; T D Oberley
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 3.  Role of IL-4 in delayed type hypersensitivity.

Authors:  G L Asherson; F Dieli; G Sireci; A Salerno
Journal:  Clin Exp Immunol       Date:  1996-01       Impact factor: 4.330

4.  Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells.

Authors:  R E Garner; A M Childress; L G Human; J E Domer
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

5.  Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte.

Authors:  D E Sabath; H E Broome; M B Prystowsky
Journal:  Gene       Date:  1990-07-16       Impact factor: 3.688

6.  Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection.

Authors:  K Kato; O Shimozato; K Hoshi; H Wakimoto; H Hamada; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

7.  Candida albicans mannan-specific, delayed hypersensitivity down-regulatory CD8+ cells are genetically restricted effectors and their production requires CD4 and I-A expression.

Authors:  S P Li; S I Lee; Y Wang; J E Domer
Journal:  Int Arch Allergy Immunol       Date:  1996-04       Impact factor: 2.749

8.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Differential immune profiles following experimental Echinostoma hortense infection in BALB/c and C3H/HeN mice.

Authors:  Yoon Kyung Cho; Yong Suk Ryang; In Sik Kim; Seung Kyu Park; Jee Aee Im; Kyu Jae Lee
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

3.  Structure determination of the exopolysaccharide produced by Lactobacillus rhamnosus strains RW-9595M and R.

Authors:  Marie-Rose Van Calsteren; Corinne Pau-Roblot; André Bégin; Denis Roy
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

4.  Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.

Authors:  Yicun Wang; Quanping Su; Shuai Dong; Hongxi Shi; Xiang Gao; Li Wang
Journal:  Hum Vaccin Immunother       Date:  2014-01-21       Impact factor: 3.452

5.  Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.

Authors:  Jyotsna Chandra; Thomas S McCormick; Yoshifumi Imamura; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

6.  Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.

Authors:  A L Baltch; R P Smith; M A Franke; W J Ritz; P B Michelsen; L H Bopp
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 7.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions.

Authors:  Héctor M Mora-Montes; Steven Bates; Mihai G Netea; Luis Castillo; Alexandra Brand; Ed T Buurman; Diana F Díaz-Jiménez; Bart Jan Kullberg; Alistair J P Brown; Frank C Odds; Neil A R Gow
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

9.  MNN5 encodes an iron-regulated alpha-1,2-mannosyltransferase important for protein glycosylation, cell wall integrity, morphogenesis, and virulence in Candida albicans.

Authors:  Chen Bai; Xiao-Li Xu; Fong-Yee Chan; Raymond Teck Ho Lee; Yue Wang
Journal:  Eukaryot Cell       Date:  2006-02

10.  Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction.

Authors:  Héctor M Mora-Montes; Steven Bates; Mihai G Netea; Diana F Díaz-Jiménez; Everardo López-Romero; Samuel Zinker; Patricia Ponce-Noyola; Bart Jan Kullberg; Alistair J P Brown; Frank C Odds; Arturo Flores-Carreón; Neil A R Gow
Journal:  Eukaryot Cell       Date:  2007-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.